Brief: BerGenBio Q4 Operating Loss At NOK 67.3 Million

Oncoinvent ASA

16/02/2022 06:06

Feb 16 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * REVENUE AMOUNTED TO NOK 0.8 MILLION (NOK 0.6 MILLION) FOR
Q4
    * Q4  OPERATING LOSS FOR QUARTER CAME TO NOK 67.3 MILLION
(NOK
71.8 MILLION)

Source text for Eikon:  ID:nWkr42qFqT 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))